Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Bisulfated peptide may be clinically useful in venous thrombotic disorders

Sep. 17, 1997

Long-term effects of abciximab in PTCA

Sep. 16, 1997

Molecumetics and Teijin begin oral thrombin inhibitor collaboration

Sep. 15, 1997

Pharmacological characterization of BIBU-52

Sep. 15, 1997

LG Chemical licenses thrombin inhibitor to Warner-Lambert

Sep. 15, 1997

Synthetic retinoids with anticoagulant effects

Sep. 15, 1997

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

Heparinase gene covered by U.S., European patents

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

Reteplase and alteplase exhibit different profiles of fibrin binding at high doses

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.